ATS 2018 International Conference - Mobile

Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials [Board No. P1333]

Location: Board no. P1333

Session Type: Thematic Poster Session

Monday

May

21

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Ruby Birk

BSc., MSc.
GSK

Chang-Qing Zhu

PhD
GSK

Rashmi Mehta

Ph.D., R.Ph.
GSK

Sally Kilbride

MSc
GSK

Colm Farrell

PhD
ICON Development Solutions

David A. Lipson

MD
GlaxoSmithKline;GSK;GSK and Perelman School of Medicine, University of Pennsylvania

Frank Barnhart

D.V.M.
GSK

Jean Brooks

MSc
GSK

View Abstract

Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials

Parent Sessions

B33 - COPD: MAINTENANCE THERAPY
05-21-2018 9:15 AM - 4:15 PM